News Archive

November 12, 2024

ALS-focused Trace Neuroscience launches with $100 million in capital

  • Portfolio Company News
Read more
October 28, 2024

Biotech Risk Cycles: Assets And Platforms

  • LifeSciVC
Read more
October 7, 2024

Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney

  • Portfolio Company News
Read more
October 2, 2024

With $115M more, Triveni accelerates immune drug work

  • Portfolio Company News
Read more
October 1, 2024

Ron Renaud’s new obesity biotech, Kailera, has $400M to go straight to Phase 3

  • Portfolio Company News
Read more